Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
amantadine
aminoacidopathies
amitriptyline
anticholinergic drugs
antihistamines
ascorbic acid
ataxia
axonopathy, distal
B 12 deficiency
blood brain barrier
bradykinesia
carbidopa
carpal tunnel syndrome
celiac disease, adult
coma
confusion
depression
drug induced neurologic disorders
drug overdose
encephalopathy
encephalopathy, metabolic
encephalopathy, neonatal
enzyme inhibition
familial
fasciculation
folic acid
gamma amino butyric acid
genetic neurologic disorders
hydrazine
hypoglycemia
hypoglycemic coma
iatrogenic neurologic disorders
inborn errors of metabolism
isoniazid
L-dopa
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
lethargy
level of consciousness, decreased
Lhermitte's sign
livedo reticularis
menopause
mental status, abnormal
metabolic acidosis
metabolic disorder, primary
metabolic disorder, primary-screening tests
monoamine oxidase inhibitors
muscle twitching
neuronopathy
neuropathy
neuropathy, iatrogenic
neuropathy, medication induced
neuropathy, peripheral
neuropathy, peripheral, treatment
neuropathy, sensory
neuropathy, toxic
neurotoxic
neurotoxin
nutritional deficiency
paresthesias
paresthesias, feet
Parkinson disease
Parkinson disease, on-off phenomena in
Parkinson disease, treatment of
penicillamine
phenelzine
phenothiazine
poison, neurologic problems with
premarin
procyclidine
progesterone
pyridoxine
pyridoxine deficiency
reserpine and reserpine like drugs
rigidity
seizure
seizure, children
seizure, drug-induced
seizure, familial
seizure, neonatal
seizure, pyridoxine dependent
seizure, treatment of
sinemet
status epilepticus
thiamine
treatment of neurologic disorder
tremor
tuberculosis
urine test for metabolic disorders
vitamin deficiency
vitamin therapy
vitamin, multiple
Showing articles 200 to 250 of 720 << Previous Next >>

The Autosomal Recessive Cerebellar Ataxias
NEJM 366:636-646, Anheim,M.,et al, 2012

Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012

Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012

Evidence-based Guideline Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults
Neurol 78:1346-1353, Holland,S.,et al, 2012

Clinicalpathologic Conference, Vitamin B12 Deficiency due to Pernicious Anemia
NEJM 366:1626-1633, Case 13-2012, 2012

Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012

In the Eye of the Cuban Epidemic Neuropathy Storm: Rosaralis Santiesteban MD PhD
MEDICC Review 13:10-15, Mills, C.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
Neurol 76:1338-1343, Arya, R.,et al, 2011

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011

Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011

Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Stroke 42:2503-2508, Hannon, N.,et al, 2011

Rivaroxaban versus Warfarin in Nonvavular Atrial Fibrillation
NEJM 365:883-891, 952, Patel, M.R.,et al, 2011

Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011

Basal Ganglia Involvement in Wernicke Encephalopathy: Report of 2 Cases
AJNR 32:E129-E131, Zuccoli, G.,et al, 2011

Dabigatran Etexilate versus Warfarin in Management of Non-Valvular Atrial Fibrillation in UK Context: Quantitative Benefit-Harm and Economic Analyses
BMJ 343:d6333, Pink, J.,et al, 2011

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

Folic Acid Supplements in Pregnancy and Severe Language Delay in Children
JAMA 36:1566-1573, Roth, C.,et al, 2011

Warfarin-Related Intraventricular Hemorrhage
Neurol 77:1840-1846, Biffi, A.,et al, 2011

Neuropathy in Parkinson Disease
Neurol 77:1947-1950, e132, Rajabally, Y.A. and Martey, J., 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage
Stroke 42:3661-3662, 3665, Steiner, T., 2011

Resumption of Oral Anticoagulation After Warfarin-Associated Intracereral Hemorrhage
Stroke 42:3663-3664, 3665, Schulman, S., 2011

Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010

Vitamin B12-Responsive Severe Leukoencephalopathy and Autonomic Dysfunction in a Patient With "Normal" Serum B12 Levels
JNNP 81:1369-1371, Graber,J.J.,et al, 2010

Association of Vitamin D Deficiency with Cognitive Impairment in Older Women: Cross-Sectional Study
Neurol 74:27-32, 13, Annweiler,C.,et al, 2010

Clinicopath Conf, The POEMS Syndrome, with Demyelinating Neuropathy and Solitary Pharmacytoma of Bone
NEJM 362:929-940, Case 7-2010, 2010

Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Systematic Review of Published and Unpublished Studies
Stroke 41:1222-1228, Lovelock,C.E., et al, 2010

Dabigatran Challenges Warfarins Superiority for Stroke Prevention in Atrial Fibrillation
Stroke 41:1307-1309, Schwartz,N.E. &Albers,G.W., 2010

Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 67:559-563, Prabhakaran,S., et al, 2010

Copper Deficiency as a Treatable Cause of Poor Balance
BMJ 340:864-866, Khaleeli,Z., et al, 2010

Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010

Management of Thrombolysis-Associated Symptomatic Intracerebral Hemorrhage
Arch Neurol 67:965-969, Goldstein,J.N., et al, 2010

Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy: The Bleeding With Antithrombotic Therapy (BAT) Study
Stroke 41:1440-1444, Toyoda,K., et al, 2010

Point-of-Care Reversal Treatment in Phenprocoumon-Related Intracerebral Hemorrhage
Ann Neurol 67:788-793, Rizos,T., et al, 2010

Delirious Deficiency
Lancet 376:1362, Olsen,R.Q &Regis,J.T., 2010

Quality of Anticoagulation Control in Atrial Fibrillation
Lancet 376:935-937, Lane,D.A. &Lip,G.Y.H., 2010

Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010

Efficacy and Safety of Dabigatran Compared With Warfarin at Different Levels of International Normalised Ratio Control for Stroke Prevention in Atrial Fibrillation: An Analysis of the RE-LY Trial
Lancet 376:975-983, Wallentin,L.,et al, 2010

Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Stroke 41:2860-2866, Majeed,A.,et al, 2010

Serum vitamin B12 and Folate Status in Patients with Inflammaotry Bowel Diseases
Eur J Med 21:320-323, Yakut, M.,et al, 2010

Small Fiber Neuropathy: A Burning Problem
Cleve Clin J Med 76:297-305, Tavee, J. & Zhou, L., 2009

Aspirin vs Anticoagulation in Carotid Artery Dissection: A Study of 298 Patients
Neurol 72:1810-1815,1800, Georgiadis,D.,et al, 2009

Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomised Non-Inferiority Trial
Lancet 374:534-542,504, Holmes,D.R.,et al, 2009

Antithrombotic Management of Patients with Prosthetic Heart Valves: Current Evidence and Future Trends
Lancet 374:565-576, Sun,J.C.J.,et al, 2009

Who Is Ineligible for Warfarin in Atrial Fibrillation?
Lancet 374:510-511, Verheugt,F.W.A., 2009



Showing articles 200 to 250 of 720 << Previous Next >>